Status: Recruiting
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
Participants needed: 12
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Nasus PharmaUpdated: Oct 9, 2026Locations: 1
Eligibility criteria
Non-smoking, male and female subjects from 18 to 65 years of age. [+8]
Known history or presence of clinically significant neurologic, hematologic, end... [+36]